Skye Bioscience Inc experienced a rather steady stock market performance.
52-week price history of SKYE Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Skye Bioscience Inc’s current trading price is -65.52% away from its 52-week high, while its distance from the 52-week low is 171.93%. The stock’s price range during the 52-week period has remained between $1.14 and $8.99. In the Healthcare sector, the company’s shares saw a trading volume of around 9.14 million for the day, which was evidently higher than the average daily volume of 0.7 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Skye Bioscience Inc (SKYE) has experienced a quarterly rise of 37.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 96.06M and boasts a workforce of 16 employees.
Making Sense of Trading Volume and Moving Average Data
Examining SKYE’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SKYE stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
SKYE Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price loss of -67.40% this year. Over the last six months, there has been a stronger performance of -4.62%. The price of SKYE fallen by 40.27% during the last 30 days period. For the last 5-days stocks have improved 51.22%.
